Please Note: You are viewing the non-styled version of SITE NAME. Either your browser does not support Cascading Style Sheets (CSS) or it is disabled. We suggest upgrading your browser to the latest version of your favorite Internet browser.
On November 18, 2015, the U.S. Food and Drug Administration (FDA) approved Narcan nasal spray for the intranasal route for naloxone administration. The intranasal route has been used as an "off-label" method of naloxone administration by the medical community for years. However, the FDA approval of this product created an avenue for pharmaceutical companies to legally manufacture and sell naloxone packaged for the intranasal route of administration.
The naloxone nasal spray has a pre-measured dose of naloxone in a device with a nozzle similar to an over-the-counter nasal spray container. In addition to its use by EMS providers, naloxone nasal spray is also prescribed by healthcare providers or dispensed by pharmacists to laypersons. At this time, Adapt Pharma Limited, the manufacturer of naloxone nasal spray, is offering special pricing to fire and EMS agencies at less than $40 per unit.
As a result of this FDA action, the Emergency Medical, Fire, and Transportation Services (EMFTS) Board has approved an updated version of the “Naloxone Administration: Intranasal Route and Auto-Injectors Education and Training Module for Ohio EMS” that includes naloxone nasal spray. Although many of you have completed the initial version of this training module, I strongly encourage all of you to review the updated version, “Naloxone Administration: Intranasal Route and Auto-Injectors Education and Training Module for Ohio EMS-Version 2.0”, to gain a foundation of knowledge about this additional avenue to treat our patients.
The PowerPoint portion of the updated training module is posted below. Completion of this naloxone training module is not mandatory; however, local training, written protocols, and medical director approval are required before the local medical director allows Ohio certified EMS providers to perform naloxone administration in the field.
The Ohio Department of Public Safety, Division of EMS is working with our training section to have this updated training module, along with instructor guidelines, testing materials, and a course completion certificate, posted on the Ohio Department of Public Safety’s Public Safety Training Campus (PSTC) in the near future as an Ohio EMS Online CE Training opportunity. A notification will be distributed when this process has been completed. In the interim, the initial version of the training module will continue to be available on the PSTC and will remain eligible for continuing education approved by the Ohio EMFTS Board.
Ohio EMFTS Board accredited and Ohio EMFTS Board approved training institutions can develop and provide this training from the PowerPoint presentations into an EMS continuing education opportunity following Ohio Administrative Code (OAC) 4765-7-09.
If you have any questions, please feel free to contact the Ohio Department of Public Safety, Division of EMS at (800) 233-0785 Thank you for your dedicated service to the residents and visitors of Ohio. The patient care that you provide on a daily basis truly has a positive impact.